Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis : result from COVAD e-survey study
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
COVID-19 has been suggested as a possible trigger of disease flares in patients with rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown. This study aimed to identify factors associated with breakthrough infection (BIs) and disease flares in patients with RA following COVID-19. We analysed data from RA patients who participated in the COVID-19 vaccination in autoimmune diseases (COVAD) study. Demographic data, patient-reported outcomes, comorbidities, pharmacologic treatment and details regarding disease flares were extracted from the COVAD database. Factors associated with disease flare-ups were determined by multivariate logistic regression analysis. The analysis comprised 1928 patients with RA who participated in the COVAD study. Younger age, Caucasian ethnicity, comorbidities with obstructive chronic pulmonary disease and asthma were associated with COVID-19 breakthrough infection. Moreover, younger age (odds ratio (OR): 0.98, 95% CI 0.96-0.99, p < 0.001), ethnicity other than Asian, past history of tuberculosis (OR: 3.80, 95% CI 1.12-12.94, p = 0.033), treatment with methotrexate (OR: 2.55, 95% CI: 1.56-4.17, p < 0.001), poor global physical health (OR: 1.07, 95% CI 1.00-1.15, p = 0.044) and mental health (OR: 0.91, 95% CI 0.87-0.95, p < 0.001) were independent factors associated disease flares in patients with RA. Our study highlights the impact of socio-demographic factors, clinical characteristics and mental health on disease flares in patients with RA. These insights may help determine relevant strategies to proactively manage RA patients at risk of flares.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Rheumatology international - 44(2024), 5 vom: 01. Apr., Seite 805-817 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Santos, Cristiana Sieiro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Breakthrough infection |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 01.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00296-024-05542-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369602390 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369602390 | ||
| 003 | DE-627 | ||
| 005 | 20240401232755.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240313s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00296-024-05542-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1359.xml |
| 035 | |a (DE-627)NLM369602390 | ||
| 035 | |a (NLM)38470502 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Santos, Cristiana Sieiro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis |b result from COVAD e-survey study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 01.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a COVID-19 has been suggested as a possible trigger of disease flares in patients with rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown. This study aimed to identify factors associated with breakthrough infection (BIs) and disease flares in patients with RA following COVID-19. We analysed data from RA patients who participated in the COVID-19 vaccination in autoimmune diseases (COVAD) study. Demographic data, patient-reported outcomes, comorbidities, pharmacologic treatment and details regarding disease flares were extracted from the COVAD database. Factors associated with disease flare-ups were determined by multivariate logistic regression analysis. The analysis comprised 1928 patients with RA who participated in the COVAD study. Younger age, Caucasian ethnicity, comorbidities with obstructive chronic pulmonary disease and asthma were associated with COVID-19 breakthrough infection. Moreover, younger age (odds ratio (OR): 0.98, 95% CI 0.96-0.99, p < 0.001), ethnicity other than Asian, past history of tuberculosis (OR: 3.80, 95% CI 1.12-12.94, p = 0.033), treatment with methotrexate (OR: 2.55, 95% CI: 1.56-4.17, p < 0.001), poor global physical health (OR: 1.07, 95% CI 1.00-1.15, p = 0.044) and mental health (OR: 0.91, 95% CI 0.87-0.95, p < 0.001) were independent factors associated disease flares in patients with RA. Our study highlights the impact of socio-demographic factors, clinical characteristics and mental health on disease flares in patients with RA. These insights may help determine relevant strategies to proactively manage RA patients at risk of flares | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Breakthrough infection | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Disease flares | |
| 650 | 4 | |a Rheumatoid arthritis | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Chen, Jun-Peng |e verfasserin |4 aut | |
| 700 | 1 | |a Nikiphorou, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Tseng, Chi-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Gutiérrez, Carlos Enrique Toro |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Ai Lyn |e verfasserin |4 aut | |
| 700 | 1 | |a Nune, Arvind |e verfasserin |4 aut | |
| 700 | 1 | |a Kadam, Esha |e verfasserin |4 aut | |
| 700 | 1 | |a Kuwana, Masataka |e verfasserin |4 aut | |
| 700 | 1 | |a Day, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Saha, Sreoshy |e verfasserin |4 aut | |
| 700 | 1 | |a Velikova, Tsvetelina |e verfasserin |4 aut | |
| 700 | 1 | |a Lilleker, James B |e verfasserin |4 aut | |
| 700 | 1 | |a Caballero-Uribe, Carlo V |e verfasserin |4 aut | |
| 700 | 1 | |a Sen, Parikshit |e verfasserin |4 aut | |
| 700 | 1 | |a Chinoy, Hector |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Rohit |e verfasserin |4 aut | |
| 700 | 1 | |a Agarwal, Vikas |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Latika |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yi-Ming |e verfasserin |4 aut | |
| 700 | 0 | |a COVAD study group |e verfasserin |4 aut | |
| 700 | 1 | |a Javaid, Mahnoor |e investigator |4 oth | |
| 700 | 1 | |a Darooka, Naitica |e investigator |4 oth | |
| 700 | 1 | |a Shinjo, Samuel Katsuyuki |e investigator |4 oth | |
| 700 | 1 | |a Parodis, Ioannis |e investigator |4 oth | |
| 700 | 1 | |a Gracia-Ramos, Abraham Edgar |e investigator |4 oth | |
| 700 | 1 | |a Knitza, Johannes |e investigator |4 oth | |
| 700 | 1 | |a Patel, Aarat |e investigator |4 oth | |
| 700 | 1 | |a Wincup, Chris |e investigator |4 oth | |
| 700 | 1 | |a Barman, Bhupen |e investigator |4 oth | |
| 700 | 1 | |a Tehozol, Erick Adrian Zamora |e investigator |4 oth | |
| 700 | 1 | |a Serrano, Jorge Rojas |e investigator |4 oth | |
| 700 | 1 | |a La Torre, Ignacio García-De |e investigator |4 oth | |
| 700 | 1 | |a Colunga-Pedraza, Iris J |e investigator |4 oth | |
| 700 | 1 | |a Merayo-Chalico, Javier |e investigator |4 oth | |
| 700 | 1 | |a Chibuzo, Okwara Celestine |e investigator |4 oth | |
| 700 | 1 | |a Shumnalieva, Russka |e investigator |4 oth | |
| 700 | 1 | |a Hoff, Leonardo Santos |e investigator |4 oth | |
| 700 | 1 | |a Kibbi, Lina El |e investigator |4 oth | |
| 700 | 1 | |a Halabi, Hussein |e investigator |4 oth | |
| 700 | 1 | |a Vaidya, Binit |e investigator |4 oth | |
| 700 | 1 | |a Hasan, ATMTanveer |e investigator |4 oth | |
| 700 | 1 | |a Salim, Babur |e investigator |4 oth | |
| 700 | 1 | |a Gheita, Tamer |e investigator |4 oth | |
| 700 | 1 | |a Saavedra, Miguel A |e investigator |4 oth | |
| 700 | 1 | |a Kardes, Sinan |e investigator |4 oth | |
| 700 | 1 | |a Andreoli, Laura |e investigator |4 oth | |
| 700 | 1 | |a Lini, Daniele |e investigator |4 oth | |
| 700 | 1 | |a Schreiber, Karen |e investigator |4 oth | |
| 700 | 1 | |a Vince, Melinda Nagy |e investigator |4 oth | |
| 700 | 1 | |a Singh, Yogesh Preet |e investigator |4 oth | |
| 700 | 1 | |a Ranjan, Rajiv |e investigator |4 oth | |
| 700 | 1 | |a Jain, Avinash |e investigator |4 oth | |
| 700 | 1 | |a Pandya, Sapan C |e investigator |4 oth | |
| 700 | 1 | |a Pilania, Rakesh Kumar |e investigator |4 oth | |
| 700 | 1 | |a Sharma, Aman |e investigator |4 oth | |
| 700 | 1 | |a Manoj, MManesh |e investigator |4 oth | |
| 700 | 1 | |a Gupta, Vikas |e investigator |4 oth | |
| 700 | 1 | |a Kavadichanda, Chengappa G |e investigator |4 oth | |
| 700 | 1 | |a Patro, Pradeepta Sekhar |e investigator |4 oth | |
| 700 | 1 | |a Ajmani, Sajal |e investigator |4 oth | |
| 700 | 1 | |a Phatak, Sanat |e investigator |4 oth | |
| 700 | 1 | |a Goswami, Rudra Prosad |e investigator |4 oth | |
| 700 | 1 | |a Chowdhury, Abhra Chandra |e investigator |4 oth | |
| 700 | 1 | |a Mathew, Ashish Jacob |e investigator |4 oth | |
| 700 | 1 | |a Shenoy, Padnamabha |e investigator |4 oth | |
| 700 | 1 | |a Asranna, Ajay |e investigator |4 oth | |
| 700 | 1 | |a Bommakanti, Keerthi Talari |e investigator |4 oth | |
| 700 | 1 | |a Shukla, Anuj |e investigator |4 oth | |
| 700 | 1 | |a Pande, Arunkumar R |e investigator |4 oth | |
| 700 | 1 | |a Chandwar, Kunal |e investigator |4 oth | |
| 700 | 1 | |a Ghodke, Akanksha |e investigator |4 oth | |
| 700 | 1 | |a Boro, Hiya |e investigator |4 oth | |
| 700 | 1 | |a Fazal, Zoha Zahid |e investigator |4 oth | |
| 700 | 1 | |a Cansu, Döndü Üsküdar |e investigator |4 oth | |
| 700 | 1 | |a Yıldırım, Reşit |e investigator |4 oth | |
| 700 | 1 | |a Gasparyan, Armen Yuri |e investigator |4 oth | |
| 700 | 1 | |a Del Papa, Nicoletta |e investigator |4 oth | |
| 700 | 1 | |a Sambataro, Gianluca |e investigator |4 oth | |
| 700 | 1 | |a Fabiola, Atzeni |e investigator |4 oth | |
| 700 | 1 | |a Govoni, Marcello |e investigator |4 oth | |
| 700 | 1 | |a Parisi, Simone |e investigator |4 oth | |
| 700 | 1 | |a Bocci, Elena Bartoloni |e investigator |4 oth | |
| 700 | 1 | |a Sebastiani, Gian Domenico |e investigator |4 oth | |
| 700 | 1 | |a Fusaro, Enrico |e investigator |4 oth | |
| 700 | 1 | |a Sebastiani, Marco |e investigator |4 oth | |
| 700 | 1 | |a Quartuccio, Luca |e investigator |4 oth | |
| 700 | 1 | |a Franceschini, Franco |e investigator |4 oth | |
| 700 | 1 | |a Sainaghi, Pier Paolo |e investigator |4 oth | |
| 700 | 1 | |a Orsolini, Giovanni |e investigator |4 oth | |
| 700 | 1 | |a De Angelis, Rossella |e investigator |4 oth | |
| 700 | 1 | |a Danielli, Maria Giovanna |e investigator |4 oth | |
| 700 | 1 | |a Venerito, Vincenzo |e investigator |4 oth | |
| 700 | 1 | |a Grignaschi, Silvia |e investigator |4 oth | |
| 700 | 1 | |a Giollo, Alessandro |e investigator |4 oth | |
| 700 | 1 | |a Alluno, Alessia |e investigator |4 oth | |
| 700 | 1 | |a Ioannone, Florenzo |e investigator |4 oth | |
| 700 | 1 | |a Fornaro, Marco |e investigator |4 oth | |
| 700 | 1 | |a Traboco, Lisa S |e investigator |4 oth | |
| 700 | 1 | |a Wibowo, Suryo Anggoro Kusumo |e investigator |4 oth | |
| 700 | 1 | |a Loarce-Martos, Jesús |e investigator |4 oth | |
| 700 | 1 | |a Prieto-González, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Gonzalez, Raquel Aranega |e investigator |4 oth | |
| 700 | 1 | |a Nakashima, Ran |e investigator |4 oth | |
| 700 | 1 | |a Sato, Shinji |e investigator |4 oth | |
| 700 | 1 | |a Kimura, Naoki |e investigator |4 oth | |
| 700 | 1 | |a Kaneko, Yuko |e investigator |4 oth | |
| 700 | 1 | |a Gono, Takahisa |e investigator |4 oth | |
| 700 | 1 | |a Tomaras, Stylianos |e investigator |4 oth | |
| 700 | 1 | |a Proft, Fabian Nikolai |e investigator |4 oth | |
| 700 | 1 | |a Holzer, Marie-Therese |e investigator |4 oth | |
| 700 | 1 | |a Gromova, Margarita Aleksandrovna |e investigator |4 oth | |
| 700 | 1 | |a Aharonov, Or |e investigator |4 oth | |
| 700 | 1 | |a Griger, Zoltán |e investigator |4 oth | |
| 700 | 1 | |a Hmamouchi, Ihsane |e investigator |4 oth | |
| 700 | 1 | |a Bouchti, Imane El |e investigator |4 oth | |
| 700 | 1 | |a Baba, Zineb |e investigator |4 oth | |
| 700 | 1 | |a Giannini, Margherita |e investigator |4 oth | |
| 700 | 1 | |a Maurier, François |e investigator |4 oth | |
| 700 | 1 | |a Campagne, Julien |e investigator |4 oth | |
| 700 | 1 | |a Meyer, Alain |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d 1985 |g 44(2024), 5 vom: 01. Apr., Seite 805-817 |w (DE-627)NLM012644315 |x 1437-160X |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2024 |g number:5 |g day:01 |g month:04 |g pages:805-817 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00296-024-05542-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2024 |e 5 |b 01 |c 04 |h 805-817 | ||